agilon health (NYSE:AGL) Shares Gap Up – Time to Buy?

agilon health, inc. (NYSE:AGL)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $4.25, but opened at $5.41. agilon health shares last traded at $5.57, with a volume of 2,663,886 shares traded.

Wall Street Analyst Weigh In

AGL has been the subject of a number of research reports. Royal Bank of Canada boosted their target price on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and raised their target price for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Finally, Sanford C. Bernstein upgraded agilon health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $3.30 to $8.50 in a report on Tuesday. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $4.37.

agilon health Trading Up 25.1 %

The business’s 50 day moving average price is $3.76 and its 200-day moving average price is $2.99. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of -5.70 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently made changes to their positions in AGL. Capital International Investors increased its holdings in shares of agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after buying an additional 9,346,295 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after buying an additional 4,706,357 shares during the period. Algert Global LLC lifted its holdings in shares of agilon health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after buying an additional 1,924,157 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after buying an additional 1,498,524 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.